文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于工程化外泌体的肿瘤转移与复发诊疗策略

Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence.

作者信息

Deng Min, Wu Shuang, Huang Peizheng, Liu Yun, Li Chong, Zheng Ji

机构信息

Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing 400037, China.

Medical Research Institute, Southwest University, Chongqing 400716, China.

出版信息

Asian J Pharm Sci. 2023 Nov;18(6):100870. doi: 10.1016/j.ajps.2023.100870. Epub 2023 Nov 29.


DOI:10.1016/j.ajps.2023.100870
PMID:38161784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10755545/
Abstract

Metastasis-associated processes are the predominant instigator of fatalities linked to cancer, wherein the pivotal role of circulating tumor cells lies in the resurgence of malignant growth. In recent epochs, exosomes, constituents of the extracellular vesicle cohort, have garnered attention within the field of tumor theranostics owing to their inherent attributes encompassing biocompatibility, modifiability, payload capacity, stability, and therapeutic suitability. Nonetheless, the rudimentary functionalities and limited efficacy of unmodified exosomes curtail their prospective utility. In an effort to surmount these shortcomings, intricate methodologies amalgamating nanotechnology with genetic manipulation, chemotherapy, immunotherapy, and optical intervention present themselves as enhanced avenues to surveil and intercede in tumor metastasis and relapse. This review delves into the manifold techniques currently employed to engineer exosomes, with a specific focus on elucidating the interplay between exosomes and the metastatic cascade, alongside the implementation of tailored exosomes in abating tumor metastasis and recurrence. This review not only advances comprehension of the evolving landscape within this domain but also steers the trajectory of forthcoming investigations.

摘要

转移相关过程是癌症相关死亡的主要诱因,其中循环肿瘤细胞的关键作用在于恶性肿瘤的复发。近年来,作为细胞外囊泡群体成分的外泌体,因其具有生物相容性、可修饰性、有效载荷能力、稳定性和治疗适用性等固有特性,在肿瘤诊疗领域受到了关注。然而,未修饰外泌体的基本功能和有限疗效限制了它们的潜在应用。为了克服这些缺点,将纳米技术与基因操作、化疗、免疫治疗和光学干预相结合的复杂方法成为监测和干预肿瘤转移及复发的更好途径。本文综述了目前用于工程化外泌体的多种技术,特别关注阐明外泌体与转移级联之间的相互作用,以及定制外泌体在减轻肿瘤转移和复发方面的应用。这篇综述不仅增进了对该领域不断变化的格局的理解,还为未来的研究指明了方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/338dc8fd3d94/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/27aee8425b89/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/0cf529dab908/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/1cafd1c911a8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/dc4447b44458/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/4e264d0ba832/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/51c8353e6185/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/ac3b2635b48b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/a3d7aa189b4f/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/338dc8fd3d94/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/27aee8425b89/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/0cf529dab908/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/1cafd1c911a8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/dc4447b44458/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/4e264d0ba832/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/51c8353e6185/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/ac3b2635b48b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/a3d7aa189b4f/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00c9/10755545/338dc8fd3d94/gr8.jpg

相似文献

[1]
Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence.

Asian J Pharm Sci. 2023-11

[2]
Engineered Exosomes as Theranostic Platforms for Cancer Treatment.

ACS Biomater Sci Eng. 2023-10-9

[3]
The role of exosomes in lung cancer metastasis and clinical applications: an updated review.

J Transl Med. 2021-7-19

[4]
Clinical Impact of Exosomes in Colorectal Cancer Metastasis.

ACS Appl Bio Mater. 2023-7-17

[5]
The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].

Cell Oncol (Dordr). 2018-4-17

[6]
Exosome Biochemistry and Advanced Nanotechnology for Next-Generation Theranostic Platforms.

Adv Mater. 2018-8-20

[7]
Advancements in engineered exosomes for wound repair: current research and future perspectives.

Front Bioeng Biotechnol. 2023-11-14

[8]
State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review.

Crit Rev Biotechnol. 2020-9

[9]
Current strategies in tailoring methods for engineered exosomes and future avenues in biomedical applications.

J Mater Chem B. 2021-8-28

[10]
Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation.

Cells. 2023-8-10

引用本文的文献

[1]
Exosomes in Hepatocellular Carcinoma: A Comprehensive Review of Current Research and Future Directions.

J Cell Mol Med. 2025-7

[2]
The Design of a Multistage Monitoring Protocol for Dendritic Cell-Derived Exosome (DEX) Immunotherapy: A Conceptual Framework for Molecular Quality Control and Immune Profiling.

Int J Mol Sci. 2025-6-6

[3]
Global hotspots and trends in pre-metastatic niche research: a bibliometric analysis(2005-2024).

Front Immunol. 2025-5-29

[4]
Exosomal miRNA-based theranostics in cervical cancer: bridging diagnostics and therapy.

Med Oncol. 2025-5-4

[5]
Identification of potential biomarkers for lung cancer using integrated bioinformatics and machine learning approaches.

PLoS One. 2025-2-27

[6]
Subcellular Organelle Targeting as a Novel Approach to Combat Tumor Metastasis.

Pharmaceutics. 2025-2-5

[7]
Advances in drug delivery systems utilizing blood cells and their membrane-derived microvesicles.

Drug Deliv. 2024-12

[8]
Stem Cell-Derived Exosomes: Natural Intercellular Messengers with Versatile Mechanisms for the Treatment of Diabetic Retinopathy.

Int J Nanomedicine. 2024

[9]
Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma.

Int J Nanomedicine. 2024

本文引用的文献

[1]
Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification.

J Nanobiotechnology. 2023-9-16

[2]
Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform.

Mater Today Bio. 2023-8-11

[3]
Curbing Exosome Communications via Introducing Artificial Membrane Receptors for Metastatic Pancreatic Cancer Therapy.

Adv Mater. 2023-9

[4]
Polymers in Engineering Extracellular Vesicle Mimetics: Current Status and Prospective.

Pharmaceutics. 2023-5-14

[5]
One-Minute Iodine Isotope Labeling Technology Enables Noninvasive Tracking and Quantification of Extracellular Vesicles in Tumor Lesions and Intact Animals.

Mol Pharm. 2023-7-3

[6]
Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy.

Mil Med Res. 2023-4-28

[7]
Engineered exosomes from different sources for cancer-targeted therapy.

Signal Transduct Target Ther. 2023-3-15

[8]
LINC00963 promotes the malignancy and metastasis of lung adenocarcinoma by stabilizing Zeb1 and exosomes-induced M2 macrophage polarization.

Mol Med. 2023-1-5

[9]
A self-guidance biological hybrid drug delivery system driven by anaerobes to inhibit the proliferation and metastasis of colon cancer.

Asian J Pharm Sci. 2022-11

[10]
Osteosarcoma-Derived Exosomes as Potential PET Imaging Nanocarriers for Lung Metastasis.

Small. 2022-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索